6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Self/non-self-discrimination by the innate immune system relies on germline-encoded, non-rearranging receptors expressed by innate immune cells recognizing conserved pathogen-associated molecular patterns. The natural killer group 2D (NKG2D) receptor is a potent immune-activating receptor that binds human genome-encoded ligands, whose expression is negligible in normal tissues, but increased in stress and disease conditions for reasons that are incompletely understood. Here it is not clear how the immune system reconciles receptor binding of self-proteins with self/non-self-discrimination to avoid autoreactivity. We now report that increased expression of NKG2D ligands after virus infection depends on interferon response factors activated by the detection of viral double-stranded RNA by pattern-recognition receptors (RIG-I/MDA-5) and that NKG2D ligand up-regulation can be blocked by the expression of viral dsRNA-binding proteins. Thus, innate immunity-mediated recognition of viral nucleic acids triggers the infected cell to release interferon for NK cell recruitment and to express NKG2D ligands to become more visible to the immune system. Finally, the observation that NKG2D-ligand induction is a consequence of signaling by pattern-recognition receptors that have been selected over evolutionary time to be highly pathogen-specific explains how the risks of autoreactivity in this system are minimized.

          Related collections

          Author and article information

          Journal
          J Biol Chem
          J. Biol. Chem
          jbc
          jbc
          JBC
          The Journal of Biological Chemistry
          American Society for Biochemistry and Molecular Biology (11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A. )
          0021-9258
          1083-351X
          15 December 2017
          6 October 2017
          : 292
          : 50
          : 20472-20480
          Affiliations
          From the []Department of Immunology and Oncology, Centro Nacional de Biotecnología/Consejo Superior de Investigaciones Científicas (CNB-CSIC), 28049 Madrid and
          the [§ ]Department of Preventive Medicine and Public Health, Universidad Autónoma, 28029 Madrid, Spain
          Author notes
          [1 ] To whom correspondence should be addressed. Tel.: 34-91-585-4849; E-mail: htreyburn@ 123456cnb.csic.es .

          Edited by Charles E. Samuel

          Article
          PMC5733586 PMC5733586 5733586 M117.818393
          10.1074/jbc.M117.818393
          5733586
          28986447
          ddb08665-81ac-42cf-8595-f3934f0f2910
          © 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
          History
          : 19 September 2017
          : 28 September 2017
          Funding
          Funded by: Consejo Superior de Investigaciones Científicas , open-funder-registry 10.13039/501100003339;
          Award ID: SAF2012-32293
          Award ID: SAF2014-58752-R
          Award ID: SAF2014-54623
          Award ID: SAF2015–69169-R
          Funded by: Instituto de Salud Carlos III , open-funder-registry 10.13039/501100004587;
          Award ID: PI11/00298
          Funded by: Consejería de Sanidad, Comunidad de Madrid , open-funder-registry 10.13039/501100006541;
          Award ID: S2010/BMD-2326
          Categories
          Immunology

          cellular immune response,virus infection,NKG2D,self/non-self-discrimination,dsRNA,double-stranded RNA (dsRNA),virus,pattern recognition receptor (PRR),natural killer cells (NK cells),NKG2D ligands

          Comments

          Comment on this article